Future Diagnostics bv: Make Our Lab Your Development Lab

      New products are the lifeblood of any company. Producing these new products on time
      and at the lowest cost possible were the reasons that Future Diagnostics was
      founded in 1997 by Mr. Frans Rosmalen. By providing professional, experienced immunoassay
      contract research and development, Future Diagnostics works with our client companies to
      expand their capabilities without expanding their permanent workforce.

      Future Diagnostics currently employs 54 people, 45 of whom are hands on laboratory          
      professionals. Over the years that we have been in business, we have developed more
      than 100 different assays. Many of these have been on large automated random access     
      instruments using paramagnetic particles and chemiluminescence detection. We also have     
      experience in manual formats such as microtiter plate assays.

      The Company has also developed and markets a line of assays and a lab on a cart
      platform targeted to niche markets such as the monitoring of endocrine surgery in real
      time, cell transplantation and brain damage assessment. Nearly 60 of these systems have been       placed through a network of distributors in Europe and the US. The flagship assay in this product       line is an intact PTH assay with a sensitivity of 6 pg/mL that produces hardcopy results within 8       minutes of the arrival of the blood sample.
     
      more >>